Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Terminated 2Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Breast 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 151Leukemia 138Leukemia, Myeloid, Acute 127Myelodysplastic Syndromes 106Precursor Cell Lymphoblastic Leukemia-Lymphoma 103Lymphoma 87Lymphoma, Non-Hodgkin 86Multiple Myeloma 84Hodgkin Disease 81Lymphoma, Mantle-Cell 71Lymphoma, Follicular 68Lymphoma, Large B-Cell, Diffuse 60Congenital Abnormalities 59Myeloproliferative Disorders 58Lymphoma, B-Cell, Marginal Zone 58Leukemia, Myeloid, Chronic-Phase 56Leukemia, Myelomonocytic, Chronic 52Leukemia, Myeloid, Accelerated Phase 50Burkitt Lymphoma 50Leukemia, Myelogenous, Chronic, BCR-ABL Positive 46Lymphoma, Large-Cell, Immunoblastic 43Anemia, Refractory, with Excess of Blasts 42Waldenstrom Macroglobulinemia 41Blast Crisis 40Primary Myelofibrosis 38Melanoma 35Recurrence 34Neoplasms, Plasma Cell 34Dendritic Cell Sarcoma, Interdigitating 30Lymphoma, T-Cell, Cutaneous 29

Interventions

Carboplatin 87Paclitaxel 77Bevacizumab 38Topotecan 23liposomal doxorubicin 22Gemcitabine 22Taxes 21Cisplatin 17Drug Therapy 14Docetaxel 14Cyclophosphamide 14pembrolizumab 13Immunoglobulin G 12Disulfides 12veliparib 8rucaparib 8mirvetuximab soravtansine 8niraparib 7Albumin-Bound Paclitaxel 7sargramostim 6Filgrastim 6Erlotinib Hydrochloride 6Doxorubicin 6pazopanib 5Granulocyte-Macrophage Colony-Stimulating Factor 5Chemotherapy, Adjuvant 5CP protocol 5trebananib 4temsirolimus 4olaparib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Fallopian Tube Neoplasms × fludarabine phosphate × Clear all
NCT01105650 2017-12-28

MT2009-30

Masonic Cancer Center, University of Minnesota

Phase 2 Completed
13 enrolled 11 charts
BreastGynecologic

Breast Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT02118285 2017-12-05

Intraperitoneal Natural Killer Cells and INCB024360 for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

Masonic Cancer Center, University of Minnesota

Phase 1 Completed
2 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡